Finally, we provide compelling evidence that inhibiting the PTK activity of FAK or its expression is sufficient to reduce the overall metastatic burden of highly aggressive breast cancers, and more specifically, that amplified TGF-β signaling in these same tumors is capable of driving the earliest steps of primary tumor metastasis, processes that are critically dependent on FAK. This evidence concerns the gene PTK2B and breast cancer.